Welcome to our dedicated page for Carecloud news (Ticker: CCLDP), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud Inc (CCLDP) delivers cloud-based healthcare IT solutions that modernize practice management and patient engagement. This news hub provides investors and medical professionals with essential updates about the company’s operational milestones, technology innovations, and financial performance.
Access real-time announcements including earnings reports, product enhancements, leadership updates, and partnership developments. Our curated collection helps stakeholders monitor CareCloud’s progress in addressing critical healthcare challenges through SaaS solutions and data analytics.
Key updates cover EHR system improvements, telehealth expansions, cybersecurity initiatives, and RCM optimization strategies. Bookmark this page for structured access to CareCloud’s evolving market position within the $XX billion healthcare IT sector.
CareCloud (CCLD) has announced the mandatory conversion of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock into Common Stock. The conversion, effective March 6, 2025, at 4:01 p.m. Eastern Time, will convert each preferred share into 7.3358 shares of Common Stock, including all accumulated and unpaid dividends.
This strategic move will eliminate approximately $7 million in annual dividend obligations, allowing the company to reinvest capital in growth initiatives. According to Norman Roth, Interim CFO, the conversion will result in a cleaner capital structure and enhanced flexibility for shareholder value creation.
Shareholders owning at least 100,000 preferred shares as of the Mandatory Exchange Date retain the right to object to the conversion. Fractional shares will be rounded up to the next whole share, and dividends on converted shares will cease to accrue on the conversion date.
CareCloud (CCLD) has announced the acquisition of MesaBilling, marking its first acquisition since Q2 2021 and signaling a renewed focus on strategic growth. The deal, finalized on February 28, 2025, though described as 'very small,' represents the company's return to its aggressive expansion strategy.
Between 2012 and 2022, CareCloud completed over 20 acquisitions, achieving a >30% compound annual growth rate (CAGR). The company plans to leverage its AI-powered revenue cycle management and automation tools to expand its healthcare provider network through this acquisition.
MesaBilling's Managing Member Marc Dobberstein expressed optimism about providing clients access to CareCloud's broader services and AI technology. Co-CEO Stephen Snyder indicated this acquisition marks the beginning of a new wave of strategic acquisitions and partnerships.
CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider for medical practices and health systems, has scheduled its fourth quarter and full year 2024 financial results announcement for March 13, 2025, before market opening. The company will host a conference call for investors at 8:30 a.m. Eastern Time.
Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only by dialing 201-389-0920. A replay will be available approximately three hours after the call's conclusion at the same link, with an audio-only option available at 412-317-6671 (access code: 13751992).
CareCloud (Nasdaq: CCLD) has announced the transfer of funds for January 2025 dividend payments on its Series A and Series B Preferred Stock. Series A stockholders will receive 22.917 cents per share, while Series B stockholders will receive 18.229 cents per share, based on the January 31, 2025 record date.
The payments are expected to be reflected in shareholders' brokerage accounts between February 18 and February 20, 2025. Both Series A and Series B Preferred Stock dividends are cumulative and payable monthly in arrears on the 15th of each month or the next business day. Due to President's Day on February 17th, payments will begin processing on February 18th.
CareCloud (Nasdaq: CCLD) has launched a new advanced referral module for its AI-enabled EHR system, achieving up to 70% time savings in referral management. The module streamlines the referral process through automation and location-based guidance, receiving an exceptional rating from 92% of surveyed users.
Key features include real-time referral completion during patient visits, location-based specialist recommendations, secure patient notifications via text messages, seamless appointment booking, and easy access to referral documentation through Personal Health Record (PHR). The system enables providers to complete referrals during patient visits and allows patients to receive specialist recommendations with integrated maps, book appointments directly, and access their referral forms securely.
CareCloud (Nasdaq: CCLD) has successfully completed its SOC 2 Type 2 examination for the second consecutive year, receiving a clean report with no exceptions. The examination, conducted by an independent CPA firm, covered security, availability, processing integrity, and confidentiality of Healthcare IT systems.
This achievement places CareCloud among an exclusive group representing less than 10% of all EHR vendors with such attestation. The certification validates the company's robust security infrastructure and demonstrates its capability to protect sensitive healthcare data, particularly important for larger enterprises such as health systems and hospital networks.
The attestation positions CareCloud for expanded growth into larger client bases, including health systems, multi-specialty group practices, and enterprise-level healthcare organizations that require stringent security and compliance frameworks for their operations.
CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
The company's management team will deliver a corporate presentation highlighting recent developments and strategic initiatives. They will also engage in one-on-one meetings with institutional and individual investors. Co-CEO Stephen Snyder emphasized several key milestones, including the planned resumption of Preferred Stock dividends in February 2025, shareholder approval for increasing authorized common shares, and strong profitability growth during 2024.
CareCloud (CCLD) held a Special Meeting where shareholders voted to approve an amendment to increase the company's authorized common stock shares from 35 million to 85 million. The meeting saw a record-breaking turnout with 10.8 million shareholders participating, representing 85% of the votes cast in favor of the proposal. Stephen Snyder, Co-Chief Executive Officer, expressed gratitude for the overwhelming shareholder support. Detailed voting results will be filed with the SEC via Form 8-K.
CareCloud (NASDAQ: CCLD) announced that shareholders have tentatively approved a proposal to increase authorized common shares from 35 million to 85 million. The company received approximately 10.4 million votes by proxy in favor of the increase, representing over 80% of total votes submitted - one of the highest levels of positive votes in the company's history. The final vote count will be announced after the Common Stock Shareholder Special Meeting on January 27, 2025.
CareCloud (CCLD) has announced the early resumption of dividend payments for its Series A and Series B Preferred Stock, citing strong financial performance and accelerated free cash flow. The Board declared dividends for January and February 2025, with payments set at $0.18229 per share for both series, payable on February 18 and March 17, 2025.
For Series A Preferred Stock, additional catch-up payments of $0.04688 per share will be included to account for previous months when dividends accumulated at 11%. The Board plans to continue the higher effective rate of 11% for approximately 8 more months before reducing it to 8.75% annually. The current redemption value for Series A shares would be $28.17, while Series B shares would be $28.43 if redeemed today.
FAQ
What is the current stock price of Carecloud (CCLDP)?
